Hikma Pharmaceuticals PLC (HIK) — Strategic Asset Allocation Index
Hikma Pharmaceuticals PLC (HIK) has a Strategic Asset Allocation Index of 49.4% as of June 2023. Strategic assets (PP&E of GBX1.09 Billion plus long-term investments of GBX-) total GBX1.09 Billion, measured against net assets of GBX2.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check HIK cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Hikma Pharmaceuticals PLC Strategic Asset Allocation Index (2004–2022)
This chart shows how Hikma Pharmaceuticals PLC's Strategic Asset Allocation Index has evolved across 19 annual periods from 2004 to 2022. As of June 2023, the index stands at 49.4%, representing strategic assets of GBX1.09 Billion against net assets of GBX2.20 Billion GBX. See HIK free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Hikma Pharmaceuticals PLC (2004–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Hikma Pharmaceuticals PLC from 2004 to 2022, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see HIK market cap overview.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.3% | GBX1.08 Billion | GBX1.08 Billion | GBX- | GBX2.15 Billion | ▲ +3.9 pp |
| 2021 | 46.5% | GBX1.15 Billion | GBX1.15 Billion | GBX- | GBX2.47 Billion | ▼ -3.3 pp |
| 2020 | 49.7% | GBX1.07 Billion | GBX1.07 Billion | GBX- | GBX2.15 Billion | ▲ +2.5 pp |
| 2019 | 47.2% | GBX1.00 Billion | GBX962.00 Million | GBX43.00 Million | GBX2.13 Billion | ▼ -6.3 pp |
| 2018 | 53.5% | GBX908.00 Million | GBX870.00 Million | GBX38.00 Million | GBX1.70 Billion | ▼ -2.1 pp |
| 2017 | 55.6% | GBX850.00 Million | GBX828.00 Million | GBX22.00 Million | GBX1.53 Billion | ▲ +14.9 pp |
| 2016 | 40.8% | GBX983.00 Million | GBX969.00 Million | GBX14.00 Million | GBX2.41 Billion | ▲ +2.6 pp |
| 2015 | 38.2% | GBX516.00 Million | GBX507.00 Million | GBX9.00 Million | GBX1.35 Billion | ▼ -5.6 pp |
| 2014 | 43.8% | GBX532.00 Million | GBX514.00 Million | GBX18.00 Million | GBX1.22 Billion | ▼ -1.4 pp |
| 2013 | 45.2% | GBX467.00 Million | GBX443.00 Million | GBX24.00 Million | GBX1.03 Billion | ▼ -4.4 pp |
| 2012 | 49.5% | GBX419.94 Million | GBX419.94 Million | GBX- | GBX847.85 Million | ▼ -3.2 pp |
| 2011 | 52.8% | GBX421.36 Million | GBX421.36 Million | GBX- | GBX798.63 Million | ▲ +10.4 pp |
| 2010 | 42.3% | GBX317.46 Million | GBX317.46 Million | GBX- | GBX750.30 Million | ▲ +0.8 pp |
| 2009 | 41.5% | GBX283.37 Million | GBX283.37 Million | GBX- | GBX683.26 Million | ▼ -3.1 pp |
| 2008 | 44.6% | GBX271.65 Million | GBX271.65 Million | GBX- | GBX609.00 Million | ▼ -12.8 pp |
| 2007 | 57.4% | GBX243.90 Million | GBX243.90 Million | GBX- | GBX424.66 Million | ▲ +12.6 pp |
| 2006 | 44.8% | GBX156.84 Million | GBX156.84 Million | GBX- | GBX349.80 Million | ▲ +13.1 pp |
| 2005 | 31.7% | GBX91.21 Million | GBX91.21 Million | GBX- | GBX287.48 Million | ▼ -17.5 pp |
| 2004 | 49.2% | GBX71.47 Million | GBX71.47 Million | GBX- | GBX145.18 Million | — |